Pune, India -- (SBWIRE) -- 03/05/2019 -- North America is the largest geographic varicose veins treatment devices market and it is expected to be the largest revenue generator during the forecast period. North American market is driven by the factors such as, increasing number of manufacturers as well as the large number of surgeries such as, new product launches by market players and high population suffering with venous diseases in the region.

The major players operating in the varicose veins treatment devices market include Alma Lasers, AngioDynamics, VVT Med, F care systems, Asclepion Laser Technologies GmbH, Syneron Medical Ltd., Energist Ltd., Medtronic, biolitec AG and Miravas among others. The market players are indulged into bringing new products to the market to keep to the pace of the competitive market nature. For instance, in November 2015, Medtronic introduced the VenaSeal closure system in the US that incorporates a novel technology for patient relief with varicose veins. Moreover, in January 2017, BTG International Canada Inc. conducted the Canadian commercial launch of Varithena, a drug-device combination product that was intended for the treatment of varicose veins. The drug-device was intended for use in adults with clinically significant venous reflux as diagnosed by duplex ultrasound.

Get Sample Copy of Research @ https://www.theinsightpartners.com/sample/TIPHE100001235/

Varicose Veins Treatment Devices Market Strategic Insights
Product launches and approvals were observed as the most adopted strategy in global varicose veins treatment devices industry. Few of the launches and approvals made by the players in the market are listed below:

2017: In November, 2018, The US Centers for Medicare and Medicaid Services (CMS) approved insurance coverage for VenaSeal procedures.

2015: In November, 2017, The Company launched its VenaSeal closure system for treating varicose veins in the lower extremities. The company uses a proprietary medical adhesive to close superficial veins in lower extremities in patients with symptomatic venous reflux, or varicose veins.

Varicose Veins Treatment Devices Market Product Insights
The global varicose veins treatment devices market by product was led by ablation devices segment. In 2017, the ablation devices segment held a largest market share of 67.1% of the varicose veins treatment devices market, by product. The segment is also expected to dominate the market during the year 2025, owing to the various technological advancements made by the market players during the recent years.

Varicose Veins Treatment Devices Market Treatment Insights
The varicose veins treatment devices market by treatment was segmented into, injection sclerotherapy, endovenous ablation, and surgical ligation. The endovenous ablation segment held the largest share of the market, by treatment. The segment is also expected to dominate during the year 2025, owing to the advantages offered by the technique that majorly include its minimally invasive nature over the traditional surgical methods, lesser complications, better and faster results and others.

Varicose Veins Treatment Devices Market End User Insights
The varicose veins end user devices market by end user was segmented into, hospitals, specialized clinics and ambulatory surgical centers. The hospitals segment held the largest share of the market, by end user with a share of around 61.9%. The segment is also expected to dominate during the year 2025, owing to increasing number of hospitals and the availability of technologically advanced options as well as techniques for the treatment of varicose veins.

Get 10% Free Customization on Purchase @ https://www.theinsightpartners.com/buy/TIPMD00002711/

About The Insight Partners
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Automotive, Electronics and Chemical industries.